Previous close | 204.92 |
Open | 204.88 |
Bid | 153.00 x 1200 |
Ask | 327.93 x 1000 |
Day's range | 203.54 - 206.36 |
52-week range | 159.21 - 255.93 |
Volume | |
Avg. volume | 538,470 |
Market cap | 20.574B |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | 53.95 |
EPS (TTM) | 3.82 |
Earnings date | 08 Feb 2023 |
Forward dividend & yield | 1.88 (0.92%) |
Ex-dividend date | 21 Nov 2022 |
1y target est | 227.00 |
STERIS' (STE) hospital capital spending is expected to have remained robust in Q3, as evident from the healthcare backlog's recent trend.
DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter financial results at 10:00 a.m. ET on February 9, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter
Today we will run through one way of estimating the intrinsic value of STERIS plc ( NYSE:STE ) by taking the expected...